Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease

Journal of Hypertension
Noriko KikuchiNobuhisa Hagiwara

Abstract

The prognosis of hypertensive patients with reduced left ventricular ejection fraction (LVEF) is poorer than that with normal LVEF. The influence of LVEF on blood pressure (BP)-lowering therapy remains unclear. The aim of this study was to clarify the impact of LVEF on clinical outcomes of BP-lowering therapy in hypertensive patients with coronary artery disease (CAD). This study was a post hoc analysis from Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Heart Disease trial, a total of 2049 hypertensive patients with CAD were included. We analyzed 1849 patients with available LVEF data on enrollment. They were divided into three groups based on LVEF; reduced (<45%, n = 386), intermediate (45-55%, n = 524), and preserved (>55%, n = 999). The 'achieved SBP' was defined as the mean value of SBP in patients who did not experience major adverse cardiac events (MACE) and the mean value of SBP prior to MACE in those who experienced MACE. During a median follow-up period of 4.2 years, MACE rates were 30.6, 27.6, and 24.0% in the reduced, intermediate, and preserved LVEF groups, respectively. A J-shaped association between achieved SBP and MACE was observed only in the preserved LVEF group [hazard ratio...Continue Reading

References

Aug 1, 1989·Circulation·E Braunwald
Dec 23, 1971·The New England Journal of Medicine·P A McKeeW B Kannel
Jun 18, 1998·American Heart Journal·M GheorghiadeR O Bonow
Mar 20, 2002·Annals of Internal Medicine·Florent BoutitieUNKNOWN INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention
Jun 21, 2002·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Nicholas G BellengerDudley J Pennell
Feb 11, 2004·Chest·Francisco Lopez-JimenezVéronique L Roger
Apr 15, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yoshiki YuiUNKNOWN Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group
Feb 18, 2005·Journal of Hypertension·Jacobus LubsenUNKNOWN ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators
Dec 24, 2008·Postgraduate Medical Journal·D J Hausenloy, D M Yellon
Mar 27, 2010·Journal of the American College of Cardiology·Simona CostanzoGiovanni de Gaetano
Jul 8, 2010·JAMA : the Journal of the American Medical Association·Rhonda M Cooper-DeHoffCarl J Pepine
Aug 21, 2010·Stroke; a Journal of Cerebral Circulation·George NtaiosPatrik Michel
Sep 18, 2010·European Heart Journal·Sripal BangaloreUNKNOWN Treating to New Targets Steering Committee and Investigators
May 18, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Akihiro NakagomiTeruo Takano
Mar 15, 2014·Stroke; a Journal of Cerebral Circulation·Jorge M LunaMitchell S V Elkind
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
coronary artery bypass
imaging techniques

Software Mentioned

CREATE
SAS
SPSS
HIJ

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.